The menopause - can business afford to ignore the potential productivity loss of 14 million days a year?
With more women working to later in life than the past, the potential issues affecting women at work who are dealing with the menopause needs to be addressed. Not only do employers have legal obligations that may arise, it is clearly in the interests of business to retain the talent and experience of these working women.
Research commissioned by ‘Health and Her’ indicates that time taken off work because of menopausal symptoms causes a productivity loss of 14 million working days annually. The Office for National Statistics demonstrate that the biggest increase in employment rates over the last 30 years have been for women aged 60 – 64 (from 18% to 41%) and for women aged 55-59 (from 49% to 69%). This increased rate of employment among women aged 50 and above means that more working women than ever before will experience the menopause. These statistics demonstrate the importance to employers of supporting women through the menopause.
The research concluded that almost a third of working women aged 50 to 64 are taking time off work to relieve menopausal symptoms and over half are then working in their own time in order to make up time. Additionally, over 370,000 women admitted that they had either left or considered leaving their career because of the difficulties of going through the menopause in the workplace which is significant and unnecessary loss of talent.
Whilst the case law on menopause related claims is currently limited, employers have a duty to protect the health and safety of their workers, and not to discriminate on grounds of sex or disability. We take a look at what we can learn from the cases to date.
In Merchant v BT plc, Ms Merchant was dismissed following a final warning for poor performance. She had previously given her manager a letter from her doctor explaining that she was “going through the menopause which can affect her level of concentration at times”. In dismissing her, the manager chose not to carry out any further medical investigations of her symptoms, in breach of BTs performance management policy. The Tribunal upheld her claims of direct sex discrimination and unfair dismissal and held that the manager would never have adopted “this bizarre and irrational approach with other non-female related conditions”. The manager was also wrong to consider that his wife’s experience was relevant evidence.
In Davies v Scottish Courts and Tribunals Service, Ms Davies suffered from menopause transition symptoms which included, amongst other things, heavy bleeding as well as stress and memory loss. Her employer considered that she had lied and brought the court services into disrepute when she advised two colleagues in court that they may have drunk water containing her medication.
Ms Davies was dismissed and successfully claimed unfair dismissal and discrimination arising from disability. The Tribunal held that her dismissal was because of her conduct arising from her disability (as her peri menopausal condition caused her to be forgetful and confused about whether she had taken her medication and put it in the water). Her employer was unable to justify the treatment as being a proportionate means of achieving a legitimate aim (having honest and trustworthy staff). The Courts and Tribunal Service has appealed this decision to the EAT, so further guidance may be forthcoming from the EAT.
It is likely that more claims will arise as the number of women over 50 in the workplace also rises. The key for employers is education to normalise the issues and effect of the menopause and to embrace debate. This will benefit employees and employers alike.
Our thinking
IBA Annual Conference
The IBA heads to Miami for its 2022 Annual Conference bringing together thousands hundreds of lawyers from around the world.
Louise Ward
What can UK investors interested in Life Sciences learn from their more experienced, including US, counterparts?
The recent tie-up between Canary Wharf and Kadans demonstrates the enthusiasm to access the lucrative UK life sciences market.
Andrew Collins
Charles Russell Speechlys advises Caretech Holdings PLC on its proposed £870.3 million take private
Charles Russell Speechlys is advising the independent board of Caretech Holdings PLC, in its take private sale to Amalfi Bidco Limited.
Rose Carey
Could the UK’s Life Sciences Vision be restricted by its Immigration Policy?
We explore some of the visa options that may be open to businesses in the sector and their relative pros and cons.
Briony Richards
AI and HR - How can employers reduce the risks associated with using artificial intelligence to help manage their workforce?
If they are not mindful of the risks associated with AI, employers may find themselves in breach of employment and data protection law.
Sophie Clark
Are workers entitled to the Bank Holiday off for the Queen’s Jubilee? Don’t bank on it!
Nick Hawkins
Nick Hawkins writes for Employment Law Journal on demystifying employment contracts
Key considerations for drafting effective post- termination restrictions
Kelvin Tanner
Brexit: Implications for Immigration
Find out what you need to know about what Brexit means for you, your workers and your organisation.
Rose Carey
Is the UK open for business? A discussion with the Home Office
We hosted an immigration webinar with the policymakers from the Home Office.
Louise Ward
Louise Ward writes for EG on what UK investors can gain from an overseas life sciences partner
What UK investors can gain from an overseas life sciences partner
Charlotte Healy
Charlotte Healy and Katie Bewick write for Pharmacy Business on expert determination
Charlotte Healy and Katie Bewick write for Pharmacy Business on expert determination
Pei Li Kew
Pei Li Kew writes for Pharmacy Business on the link between pharmacy and IP
Pei Li Kew writes for Pharmacy Business on the link between pharmacy and IP
Is the UK open for business? A discussion with the Home Office
Join our Immigration team for a live webinar with policymakers from the Home Office.
Rose Carey
Relocating to the UK – Post Tier 1 (Investor)
The UK government closed the Tier 1 Investor visa route with immediate effect on 17 February 2022.
Lesley O’Leary
Briefing publishes Lesley O’Leary 's comments on hybrid working and the impact on collaboration
Briefing publishes Lesley O’Leary 's comments on hybrid working and the impact on collaboration
Emily Chalkley
How to tackle a large Gender Pay Gap
Nick Hawkins
Nick Hawkins writes for Employment Law Journal on demystifying employment contracts
Nick Hawkins explains the key legal principles that govern contracts of employment.
Michael Powner
Michael Powner and Emily Chalkley write for People Management on who pays the price for vicarious liability
Michael Powner and Emily Chalkley explain whether an employer should ever be liable for wrongdoing committed by their employees.
Katherine Dennis
New Global Mobility visa route – coming Spring 2022
A new Global Business Mobility visa route is launching in the Spring of 2022.
Clare Davis
National Minimum Wage – At risk of committing a criminal offence?
To best prepare, you need to understand the nature of the risks involved and take steps to minimise them.